Sai Parenteral's share price is ₹593.1 as of 21 Jun, 2026. The stock Sai Parenteral's intraday movement has stayed between ₹578.15 and ₹597.00, while on a 52-week basis,Sai Parenteral's price 52 week high is ₹598.00 & its 52 week low is ₹400.00.
In terms of trading activity, Sai Parenteral's has recorded a volume of 294950 shares, The Sai Parenteral's has a market cap of ₹44179231 CR. The stock’s Average Traded Price (ATP) stands at ₹587.67, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50 @ ₹593.10.
Sai Parenteral's operates within a circuit range of ₹467.40 – ₹701.00, with a Value of ₹17.33 CR. The Delivery Percentage for the day is 41.33%. Additionally, Sai Parenteral's currently falls under the No framework, and trades with a market lot size of 1.
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Sai Parenterals secured a USD 11 million (Rs. 104.50 crore) order from The Pill Corp, Philippines. This 10-year exclusive contract is for the supply of anti-TB products in the Philippines market.
May 28 2026 20:13:34
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Sai Parenterals announced the audio recording of its Post Earnings (Group Conference) Call for Q4 and year ended March 31, 2026, is available. Investors can access the recording via the company's website for details on financial performance.
May 27 2026 21:10:14
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sai Parenterals delivered robust Q4 FY26 results, with revenue increasing 166.65% YoY to Rs.197.93 crore and net profit up 736.04% to Rs.13.25 crore. Full-year FY26 revenue grew 140.37% to Rs.380.99 crore, demonstrating strong growth momentum.
May 23 2026 20:13:24
Sai Parenterals Ltd - 544742 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 23.05.2026
Sai Parenterals reported audited FY26 consolidated revenue of ₹381.00 cr and a net profit of ₹14.26 cr. Additionally, its subsidiary acquired a 74.64% stake in Noumed Life Sciences (UK) for AUD 22 million to expand its global footprint.
The Buying Price of Sai Parenteral's share is 593.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sai Parenteral's stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sai Parenteral's, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sai Parenteral's shares is 183.72. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sai Parenteral's shares is 3.39. Useful to assess the stock's value relative to its book value.
To assess Sai Parenteral's’s valuation compare Sector P/E, P/B which are 69.22 & 3.06 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sai Parenteral's is 2620.27 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sai Parenteral's share price is 598.00 & 400.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sai Parenteral's belongs to the Healthcare sector.